A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Keisha Smith
Amy Pace
Stephan Ortiz
Shamsah Kazani
Scott Rottinghaus
机构：
[1] Alexion Pharmaceuticals,Medical Writing
[2] Alexion Pharmaceuticals,Quantitative Sciences
[3] Alexion Pharmaceuticals,Clinical Pharmacology
[4] Alexion Pharmaceuticals,Department of Clinical Development Sciences
[5] Inc.,undefined
来源：
Trials | / 21卷
关键词：
COVID-19; severe acute respiratory distress syndrome coronavirus 2; lung injury; acute respiratory distress syndrome; respiratory distress syndrome; severe pneumonia; severe acute respiratory syndrome; acute pneumonia; viral; ravulizumab; antibodies; monoclonal; humanized; complement; complement inhibitor; Ultomiris; hospitalization; randomized controlled study; adult;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial
    Smith, Keisha
    Pace, Amy
    Ortiz, Stephan
    Kazani, Shamsah
    Rottinghaus, Scott
    TRIALS, 2020, 21 (01)
  • [2] Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Roehrig, Stefan
    Hssain, Ali Ait
    Shallik, Nabil Al Hamid
    Elsaid, Ingi Mohamed A.
    Mustafa, Salma Faisal
    Smain, Osama A. M.
    Molokhia, Ashraf Abdulla
    Lance, Marcus D.
    TRIALS, 2020, 21 (01)
  • [3] Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Stefan Roehrig
    Ali Ait Hssain
    Nabil Al Hamid Shallik
    Ingi Mohamed A. Elsaid
    Salma Faisal Mustafa
    Osama A. M. Smain
    Ashraf Abdulla Molokhia
    Marcus D. Lance
    Trials, 21
  • [4] High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
    Luis Patricio Maskin
    Gabriel Leonardo Olarte
    Fernando Palizas
    Agostina E. Velo
    María Fernanda Lurbet
    Ignacio Bonelli
    Natalio D. Baredes
    Pablo Oscar Rodríguez
    Trials, 21
  • [5] High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
    Patricio Maskin, Luis
    Leonardo Olarte, Gabriel
    Palizas Jr, Fernando
    Velo, Agostina E.
    Fernanda Lurbet, Maria
    Bonelli, Ignacio
    Baredes, Natalio D.
    Oscar Rodriguez, Pablo
    TRIALS, 2020, 21 (01)
  • [6] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Jonathan Rilinger
    Winfried V. Kern
    Daniel Duerschmied
    Alexander Supady
    Christoph Bode
    Dawid L. Staudacher
    Tobias Wengenmayer
    Trials, 21
  • [7] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Rilinger, Jonathan
    Kern, Winfried V.
    Duerschmied, Daniel
    Supady, Alexander
    Bode, Christoph
    Staudacher, Dawid L.
    Wengenmayer, Tobias
    TRIALS, 2020, 21 (01)
  • [8] Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
    Concepción Payares-Herrera
    María E. Martínez-Muñoz
    Inés Lipperheide Vallhonrat
    Rosa Malo de Molina
    Manuel Pérez Torres
    Andrea Trisan
    Isabel Salcedo de Diego
    Rosalía Alonso
    Rocío Zafra
    Trinidad Donaire
    Rocío Sánchez
    Juan José Rubio
    Rafael F. Duarte Palomino
    Cristina Avendaño Solá
    Trials, 22
  • [9] Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
    Payares-Herrera, Concepcion
    Martinez-Munoz, Maria E.
    Vallhonrat, Ines Lipperheide
    de Molina, Rosa Malo
    Torres, Manuel Perez
    Trisan, Andrea
    de Diego, Isabel Salcedo
    Alonso, Rosalia
    Zafra, Rocio
    Donaire, Trinidad
    Sanchez, Rocio
    Rubio, Juan Jose
    Duarte Palomino, Rafael F.
    Sola, Cristina Avendano
    TRIALS, 2021, 22 (01)
  • [10] Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
    Gorman, Ellen
    Shankar-Hari, Manu
    Hopkins, Phil
    Tunnicliffe, William S.
    Perkins, Gavin D.
    Silversides, Jonathan
    McGuigan, Peter
    Jackson, Colette
    Boyle, Roisin
    McFerran, Jamie
    McDowell, Cliona
    Campbell, Christina
    McFarland, Margaret
    Smythe, Jon
    Thompson, Jacqui
    Williams, Barry
    Curley, Gerard
    Laffey, John G.
    Clarke, Mike
    O'Kane, Cecilia
    McAuley, Daniel F.
    TRIALS, 2020, 21 (01)
12345